Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Imfinzi (durvalumab)
Marketing
AZ, Genentech, Merck top oncology HCP promotions: report
Interactions between cancer drugmakers and oncologists are dominated by therapies boasting a broad reach and targeting common cancers, per ZoomRx.
Andrea Park
Aug 14, 2025 11:52am
ASCO: AZ looks to bring immunotherapy to early stomach cancer
Jun 1, 2025 8:00am
AZ's Imfinzi checks off a win in high-risk bladder cancer study
May 9, 2025 10:14am
AZ's Imfinzi wins perioperative FDA nod in bladder cancer
Mar 31, 2025 12:34pm
AstraZeneca says Imfinzi keeps stomach cancer from coming back
Mar 7, 2025 9:48am
BMS's Opdivo scores overall survival triumph in NSCLC trial
Feb 19, 2025 10:06am
